SeqLL Inc. (SQL)

NASDAQ: SQL · IEX Real-Time Price · USD
0.420
0.00 (0.00%)
Mar 31, 2023, 11:53 AM EDT - Market open
Market Cap 5.70M
Revenue (ttm) 78,659
Net Income (ttm) -4.09M
Shares Out 13.89M
EPS (ttm) -0.34
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 15,732
Open 0.410
Previous Close 0.420
Day's Range 0.406 - 0.420
52-Week Range 0.230 - 2.400
Beta n/a
Analysts Buy
Price Target 3.06 (+628.57%)
Earnings Date May 12, 2023

About SQL

SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. The company designs, develops, and manufactures genetic analysis technologies. It offers true single molecule sequencing (tSMS) platform, which offers a single molecule solution for DNA and RNA sequencing. The company has a collaboration agreement with Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc. It serves academic and government ... [Read more]

Sector Healthcare
IPO Date Aug 27, 2021
Employees 7
Stock Exchange NASDAQ
Ticker Symbol SQL
Full Company Profile

Financial Performance

In 2022, SeqLL's revenue was $78,659, a decrease of -62.54% compared to the previous year's $209,995. Losses were -$4.09 million, 10.6% more than in 2021.

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for SQL stock is "Buy." The 12-month stock price forecast is $3.06, which is an increase of 628.57% from the latest price.

Price Target
$3.06
(628.57% upside)
Analyst Consensus: Buy
Stock Forecasts

News

SeqLL Announces Fourth Quarter and Year End 2022 Financial Results

BILLERICA, Mass., March 17, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services, tod...

2 weeks ago - GlobeNewsWire

SeqLL Inc. Announces Closing of $1.8 Million Registered Direct Offering

BILLERICA, Mass., Feb. 15, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. (Nasdaq: SQL and SQLLW) (“SeqLL” or the “Company”), a technology company providing life sciences instrumentation and research services, t...

1 month ago - GlobeNewsWire

SeqLL Inc. Announces Pricing of $1.8 Million Registered Direct Offering

BILLERICA, Mass., Feb. 13, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. (NASDAQ: SQL and SQLLW) (“SeqLL” or the “Company”), a technology company providing life sciences instrumentation and research services, t...

1 month ago - GlobeNewsWire

SeqLL stock rockets on heavy volume again, in wake of 2-year development pact with FBI

Shares of SeqLL Inc. SQL, -38.69% more than doubled on heavy volume ahead of Friday's open, in the wake of the genetic sequencing company's announcement earlier in the week about an product developmen...

1 month ago - Market Watch

Why Is SeqLL (SQL) Stock Up 126% Today?

SeqLL (NASDAQ: SQL) stock is taking off on Friday morning despite a lack of news from the forensic company. Instead, it looks like traders can thank heavy trading for the boost to SQL's stock price t...

1 month ago - InvestorPlace

Why Is SeqLL (SQL) Stock Up 256% Today?

SeqLL (NASDAQ: SQL) stock is seeing massive gains on Tuesday after signing a new contract with a government agency. Specifically, the company has signed a two-year Cooperative Research and Developmen...

1 month ago - InvestorPlace

SeqLL Announces CRADA with the FBI

BILLERICA, Mass., Feb. 07, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL”, NASDAQ: SQL), a technology company providing life sciences instrumentation and research services, today announced the establish...

1 month ago - GlobeNewsWire

Brian Paras joins SeqLL as Chief Business Officer

BILLERICA, Mass., Dec. 13, 2022 (GLOBE NEWSWIRE) --  SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL), a technology company providing life sciences instrumentation and research services, today anno...

3 months ago - GlobeNewsWire

SeqLL Provides Third Quarter 2022 Financial Results

BILLERICA, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services aimed...

5 months ago - GlobeNewsWire

UPDATE -- SeqLL Announces Peer-Reviewed Publication of Novel Single-Molecule Liquid Biopsy Method in Nature Biotechnology

BILLERICA, Mass., Sept. 13, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL), a technology company providing life sciences instrumentation and research services, today anno...

7 months ago - GlobeNewsWire

SeqLL Announces Peer-Reviewed Publication of Novel Single-Molecule Liquid Biopsy Method in Nature Biotechnology

BILLERICA, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL), a technology company providing life sciences instrumentation and research services, today anno...

7 months ago - GlobeNewsWire

SeqLL to Present at the H.C. Wainwright 24th Annual Global Conference

BILLERICA, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services for ...

7 months ago - GlobeNewsWire

SeqLL Inc. Receives Nasdaq Notification Regarding Minimum Bid Requirements

BILLERICA, Mass., June 24, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. (NASDAQ: SQL and SQLLW) (“SeqLL” or the “Company”), a technology company providing life sciences instrumentation and research services in...

9 months ago - GlobeNewsWire

SeqLL's Single-Molecule Nucleosome Imaging Method Published in Peer Reviewed Cell Reports Journal

BILLERICA, Mass., June 13, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services in co...

10 months ago - GlobeNewsWire

SeqLL Provides First Quarter 2022 Financial Results and a Corporate Update

BILLERICA, Mass., May 13, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services in col...

11 months ago - GlobeNewsWire

6 Stocks Halted In Thursday's Session

A circuit breaker is an automatic, temporary trading halt on certain securities when the underlying stock is experiencing times of high volatility. It's a measure put in place to help restore and brin...

Other symbols: FRGEGYROIMTEOXBR
1 year ago - Benzinga

SeqLL Announces Fourth Quarter and Year End 2021 Financial Results and Provides a Corporate Update

BILLERICA, Mass., March 30, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services in c...

1 year ago - GlobeNewsWire

SeqLL to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest

BILLERICA, Mass., March 24, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services for ...

1 year ago - GlobeNewsWire

SeqLL Announces Formation of Scientific Advisory Board

BILLERICA, Mass., March 21, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services for ...

1 year ago - GlobeNewsWire

SeqLL Inc. Announces Closing of Underwriters' Option to Purchase Additional Shares of Common Stock in Connection with its Initial Public Offering

WOBURN, Mass., Sept. 29, 2021 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ:SQL; SQLLW), a development-stage life sciences instrumentation and research services company engaged in ...

1 year ago - GlobeNewsWire

SeqLL Announces Publication of a New Single-Cell Epitranscriptomic Method Powered by SeqLL's tSMS® Platform

Method developed by leading researchers at the Bernstein Laboratory and SeqLL Inc.

1 year ago - GlobeNewsWire

7 Biotech Stocks to Buy That Have Millionaire-Maker Potential

This sector is always a risky area to gamble in. If you have the stomach for it, however, these biotech stocks could see massive gains.

Other symbols: AVIRHSTONRBONVIVPRVB
1 year ago - InvestorPlace